Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Nature Medicine

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Wearable sensor data and self-reported symptoms for COVID-19 detection.  27:73-77. 2021
  • The proximal origin of SARS-CoV-2.  26:450-452. 2020
  • Engineered immunogen binding to alum adjuvant enhances humoral immunity.  26:430-440. 2020
  • Looking forward 25 years: the future of medicine.  25:1804-1807. 2019
  • A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.  25:1377-1384. 2019
  • The future of individualized health maintenance.  25:712-714. 2019
  • Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.  25:628-640. 2019
  • Precision epidemiology for infectious disease control.  25:206-211. 2019
  • High-performance medicine: the convergence of human and artificial intelligence.  25:44-56. 2019
  • DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.  24:1151-1156. 2018
  • Senolytics improve physical function and increase lifespan in old age.  24:1246-+. 2018
  • A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.  24:401-407. 2018
  • Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.  24:194-202. 2018
  • Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.  23:1362-1368. 2017
  • Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation.  23:1287-1297. 2017
  • Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.  23:878-884. 2017
  • Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.  23:120-127. 2017
  • Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.  22:1108-1119. 2016
  • 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.  22:1050-1055. 2016
  • International AIDS Society global scientific strategy: towards an HIV cure 2016.  22:839-850. 2016
  • Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.  22:262-269. 2016
  • Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.  22:439-445. 2016
  • Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.  22:78-83. 2016
  • PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells.  21:1307-1317. 2015
  • GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.  20:886-896. 2014
  • Translational strategies and challenges in regenerative medicine.  20:814-821. 2014
  • Another HIV vaccine failure: where to next?.  19:1576-1577. 2013
  • Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.  19:1039-1046. 2013
  • Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.  19:1030-1038. 2013
  • MSCs: science and trials.  19:812. 2013
  • A colorectal cancer classification system that associates cellular phenotype and responses to therapy.  19:619-625. 2013
  • Coagulation factor defends adenovirus from immune attack.  19:406-7. 2013
  • Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome.  19:473-480. 2013
  • Exploring the epigenetics of cocaine resistance.  19:136-137. 2013
  • Annotating MYC status with 89-Zr-transferrin imaging.  18:1586-1591. 2012
  • MDM4 is a key therapeutic target in cutaneous melanoma.  18:1239-1247. 2012
  • Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.  18:1232-8. 2012
  • Pharmacological targeting of the thrombomodulin-activated protein c pathway mitigates radiation toxicity.  18:1123-9. 2012
  • Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin.  18:564-571. 2012
  • Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.  18:159-165. 2012
  • Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.  17:1490-1497. 2011
  • The TLX1 oncogene drives aneuploidy in T cell transformation.  16:1321-1327. 2010
  • Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis.  16:1152-1156. 2010
  • Passive neutralizing antibody controls shiv viremia and enhances b cell responses in infant macaques.  16:1117-1119. 2010
  • Neutrophils release brakes of coagulation.  16:851-852. 2010
  • Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.  15:1407-1413. 2009
  • Synovial fibroblasts spread rheumatoid arthritis to unaffected joints.  15:1414-20. 2009
  • CCL3L1 and HIV/AIDS susceptibility.  15:1110-1112. 2009
  • Effective, low-titer antibody protection against low-dose repeated mucosal shiv challenge in macaques.  15:951-954. 2009
  • Neutralizing antibodies generated during natural hiv-1 infection: Good news for an hiv-1 vaccine?.  15:866-870. 2009
  • Tilting toward immunosuppression.  15:496-497. 2009
  • The CREB1 coactivator Crtc1 is required for energy balance and fertility.  14:1112-1117. 2008
  • Expression of a noncoding rna is elevated in alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.  14:723-730. 2008
  • Nonhuman primate models and the failure of the merck hiv-1 vaccine in humans.  14:617-621. 2008
  • Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.  14:25-27. 2008
  • The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.  14:45-54. 2008
  • Extralymphatic virus sanctuaries as a consequence of potent T-cell activation.  13:1316-1323. 2007
  • Protein carbamylation links inflammation, smoking, uremia and atherogenesis.  13:1176-1184. 2007
  • Broad hiv-1 neutralization mediated by cd4-binding site antibodies.  13:1032-1034. 2007
  • Essential role of stromally induced hedgehog signaling in B-cell malignancies.  13:944-951. 2007
  • TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.  13:543-551. 2007
  • Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.  13:439-447. 2007
  • Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.  12:1410-1416. 2006
  • Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.  12:1278-1285. 2006
  • Interleukin-10 determines viral clearance or persistence in vivo.  12:1301-1309. 2006
  • Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination.  12:1310-1315. 2006
  • Side effects may include evolution.  12:890-891. 2006
  • Channeling pain.  12:506-507. 2006
  • Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior.  12:526-533. 2006
  • Viral nanoparticles as tools for intravital vascular imaging.  12:354-360. 2006
  • A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy.  12:128-132. 2006
  • Platelets mediate cytotoxic T lymphocyte-induced liver damage.  11:1167-1169. 2005
  • Role of isg15 protease ubp43 (usp18) in innate immunity to viral infection.  10:1374-1378. 2004
  • Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.  10:1379-1383. 2004
  • Tcr affinity and negative regulation limit autoimmunity.  10:1234-1239. 2004
  • Molecular pathways to neurodegeneration.  10:S2-S9. 2004
  • Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.  10:502-509. 2004
  • Sporadic ALS: blame it on the editor.  10:347-347. 2004
  • gp41: HIV's shy protein.  10:133-134. 2004
  • Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.  10:712-718. 2004
  • Genetic deficiency in pparg does not alter development of experimental prostate cancer.  9:1265-1266. 2003
  • Activated protein c blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.  9:338-342. 2003
  • Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to hiv-1 gp120.  9:343-346. 2003
  • A DNA vaccine against vegf receptor 2 prevents effective angiogenesis and inhibits tumor growth.  8:1369-1375. 2002
  • Platelets in atherothrombosis.  8:1227-1234. 2002
  • Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis.  8:1004-1010. 2002
  • The t(8;21) fusion protein, aml1-eto, specifically represses the transcription of the p14(arf) tumor suppressor in acute myeloid leukemia.  8:743-750. 2002
  • New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.  8:392-398. 2002
  • Differential regulation of antiviral T-cell immunity results in stable CD8(+) but declining CD4(+) T-cell memory.  7:913-919. 2001
  • Is tissue plasminogen activator a threat to neurons?.  7:17-18. 2001
  • Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway.  5:1370-1374. 1999
  • Integration of endoplasmic reticulum signaling in health and disease.  5:745-751. 1999
  • Neuroprotection by a caspase inhibitor in acute bacterial meningitis.  5:298-302. 1999
  • Shakespeare in love - with NMDA receptors?.  5:270-271. 1999
  • Prp expression in b lymphocytes is not required for prion neuroinvasion.  4:1429-1433. 1998
  • Activators of the nuclear receptor ppar gamma enhance colon polyp formation.  4:1058-1061. 1998
  • Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.  4:228-231. 1998
  • Passive immunization with a human monoclonal antibody protects hu-pbl-scid mice against challenge by primary isolates of hiv-1.  3:1389-1393. 1997
  • The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells.  3:1383-1388. 1997
  • Primary demyelination in transgenic mice expressing interferon-gamma.  3:1037-1041. 1997
  • Antiviral pressure exerted by hiv-1-specific cytotoxic t lymphocytes (ctls) during primary infection demonstrated by rapid selection of ctl escape virus.  3:205-211. 1997
  • Janus faces of NF-κB: Neurodestruction versus neuroprotection.  3:20-22. 1997
  • A model of measles virus-induced immunosuppression: Enhanced susceptibility of neonatal human pbls.  2:1250-1254. 1996
  • The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.  2:1104-1108. 1996
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1078-8956

Electronic International Standard Serial Number (EISSN)

  • 1546-170X

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support